Limited Value of Cystatin-C over Estimated Glomerular Filtration Rate for Heart Failure Risk Stratification
Zamora, Elisabet (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
de Antonio Ferrer, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Vila, Joan (Institut Hospital del Mar d'Investigacions Mèdiques)
Galán, Amparo (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Gastelurrutia, Paloma (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Urrutia de Diego, Agustín (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Data: |
2012 |
Resum: |
Background: to compare the prognostic value of estimated glomerular filtration rate, cystatin-C, an alternative renal biomarker, and their combination, in an outpatient population with heart failure. Estimated glomerular filtration rate is routinely used to assess renal function in heart failure patients. We recently demonstrated that the Cockroft-Gault formula is the best among the most commonly used estimated glomerular filtration rate formulas for predicting heart failure prognosis. Methodology: a total of 879 consecutive patients (72% men, age 70. 4 years [P25-75 60. 5-77. 2]) were studied. The etiology of heart failure was mainly ischemic heart disease (52. 7%). The left ventricular ejection fraction was 34% (P25-75 26-43%). Most patients were New York Heart Association class II (65. 8%) or III (25. 9%). During a median follow-up of 3. 46 years (P25-75 1. 85-5. 05), 312 deaths were recorded. In an adjusted model, estimated glomerular filtration rate and cystatin-C showed similar prognostic value according to the area under the curve (0. 763 and 0. 765, respectively). In Cox regression, the multivariable analysis hazard ratios were 0. 99 (95% CI: 0. 98-1, P = 0. 006) and 1. 14 (95% CI: 1. 02-1. 28, P = 0. 02) for estimated glomerular filtration rate and cystatin-C, respectively. Reclassification, assessed by the integration discrimination improvement and the net reclassification improvement indices, was poorer with cystatin-C (−0. 5 [−1. 0;−0. 1], P = 0. 024 and −4. 9 [−8. 8;−1. 0], P = 0. 013, respectively). The value of cystatin-C over estimated glomerular filtration rate for risk-stratification only emerged in patients with moderate renal dysfunction (eGFR 30-60 ml/min/1. 73 m2, chi-square 12. 9, P<0. 001). Conclusions: taken together, the results indicate that estimated glomerular filtration rate and cystatin-C have similar long-term predictive values in a real-life ambulatory heart failure population. Cystatin-C seems to offer improved prognostication in heart failure patients with moderate renal dysfunction. |
Drets: |
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
Llengua: |
Anglès |
Document: |
Article ; recerca ; Versió publicada |
Matèria: |
Heart failure ;
Glomerular filtration rate ;
Creatinine ;
Prognosis ;
Renal system ;
Biomarkers ;
Etiology ;
Diabetes mellitus |
Publicat a: |
PloS one, Vol. 7 Issue 12 (December 2012) , p. e51234, ISSN 1932-6203 |
DOI: 10.1371/journal.pone.0051234
PMID: 23240006
El registre apareix a les col·leccions:
Documents de recerca >
Documents dels grups de recerca de la UAB >
Centres i grups de recerca (producció científica) >
Ciències de la salut i biociències >
Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)Articles >
Articles de recercaArticles >
Articles publicats
Registre creat el 2015-10-19, darrera modificació el 2024-06-01